Xiaojun Han
16Patents
7h-index
29Co-inventors
62Inventor score
Filing activity: Dec 5, 2003 → Apr 15, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7220862B2 | Calcitonin gene related peptide receptor antagonists | Physics | 11 | Expired |
| US7314883B2 | Anti-migraine treatments | Physics | 11 | Active |
| US7842808B2 | Anti-migraine spirocycles | Physics | 10 | Active |
| US7834007B2 | CGRP antagonists | Chemistry; Metallurgy | 9 | Active |
| US10266578B2 | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof | Human Necessities | 9 | Active |
| US7772244B2 | Therapeutic agents for the treatment of migraine | Human Necessities | 9 | Active |
| US7244746B2 | Imidazolyl derivatives as corticotropin releasing factor inhibitors | Chemistry; Metallurgy | 8 | Expired |
| US7125990B2 | Imidazolyl derivatives as corticotropin releasing factor inhibitors | Chemistry; Metallurgy | 1 | Expired |
| US10968219B2 | 3-substituted propionic acids as αV integrin inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11224634B2 | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof | General | 0 | Revoked |
| US12097242B2 | Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides | Human Necessities | 0 | Active |
| US12097241B2 | Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides | Human Necessities | 0 | Active |
| US11884661B2 | 3-substituted propionic acids as αV integrin inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7470680B2 | Constrained compounds as CGRP-receptor antagonists | Human Necessities | 0 | Active |
| US11364281B2 | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof | Human Necessities | 0 | Active |
| US11185570B2 | Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.